RUNDC2A-NCAN Fusion FISH Probe
The RUNDC2A-NCAN Fusion FISH Probe is used to confirm a fusion of the RUNDC2A and NCAN genes. The fusion of the RUNDC2A and NCAN genes has been associated with Bladder Urothelial Carcinoma. These probes are FISH confirmed on normal peripheral blood in both interphase nuclei and metaphase spreads before shipment. Typical turnaround time for this product is 7-14 days after purchase.
** This product is for in vitro and research use only. This product is not intended for diagnostic use.
SKU | Test Kits | Buffer | Dye Color | Order Now |
---|---|---|---|---|
RUNDC2A-NCAN-20-ORGR (Standard Design) | 20 (40 μL) | 200 μL | ||
RUNDC2A-NCAN-20-RERE | 20 (40 μL) | 200 μL | ||
RUNDC2A-NCAN-20-REOR | 20 (40 μL) | 200 μL | ||
RUNDC2A-NCAN-20-REGO | 20 (40 μL) | 200 μL | ||
RUNDC2A-NCAN-20-REGR | 20 (40 μL) | 200 μL | ||
RUNDC2A-NCAN-20-REAQ | 20 (40 μL) | 200 μL | ||
RUNDC2A-NCAN-20-ORRE | 20 (40 μL) | 200 μL | ||
RUNDC2A-NCAN-20-OROR | 20 (40 μL) | 200 μL | ||
RUNDC2A-NCAN-20-ORGO | 20 (40 μL) | 200 μL | ||
RUNDC2A-NCAN-20-ORAQ | 20 (40 μL) | 200 μL | ||
RUNDC2A-NCAN-20-GORE | 20 (40 μL) | 200 μL | ||
RUNDC2A-NCAN-20-GOOR | 20 (40 μL) | 200 μL | ||
RUNDC2A-NCAN-20-GOGO | 20 (40 μL) | 200 μL | ||
RUNDC2A-NCAN-20-GOGR | 20 (40 μL) | 200 μL | ||
RUNDC2A-NCAN-20-GOAQ | 20 (40 μL) | 200 μL | ||
RUNDC2A-NCAN-20-GRRE | 20 (40 μL) | 200 μL | ||
RUNDC2A-NCAN-20-GROR | 20 (40 μL) | 200 μL | ||
RUNDC2A-NCAN-20-GRGO | 20 (40 μL) | 200 μL | ||
RUNDC2A-NCAN-20-GRGR | 20 (40 μL) | 200 μL | ||
RUNDC2A-NCAN-20-GRAQ | 20 (40 μL) | 200 μL | ||
RUNDC2A-NCAN-20-AQRE | 20 (40 μL) | 200 μL | ||
RUNDC2A-NCAN-20-AQOR | 20 (40 μL) | 200 μL | ||
RUNDC2A-NCAN-20-AQGO | 20 (40 μL) | 200 μL | ||
RUNDC2A-NCAN-20-AQGR | 20 (40 μL) | 200 μL | ||
RUNDC2A-NCAN-20-AQAQ | 20 (40 μL) | 200 μL |
NCAN Gene Summary
Neurocan is a chondroitin sulfate proteoglycan thought to be involved in the modulation of cell adhesion and migration.[supplied by OMIM, Jul 2002]
Gene Name: Neurocan
Chromosome: CHR19: 19322781 -19363061
Locus: 19p13.11
Gene Diseases
The RUNDC2A NCAN Fusion has been associated with the following diseases:
Disease Name |
---|
Bladder Urothelial Carcinoma |
FISH Probe Protocols
Protocol, Procedure, or Form Name | Last Modified | Download |
---|